IP Library Assignment 072558/0762
Patent Assignment
Reel/Frame 072558/0762

Assignment of Assignor's Interest

Recorded: 2025-10-14 Pages: 6
Assignors
WU, ZHAO
Executed: 2025-10-10
LIU, ZHIGANG
Executed: 2025-10-13
XIAO, LEI
Executed: 2025-10-13
PU, CHENGFEI
Executed: 2025-10-09
CAO, ZHIYUAN
Executed: 2025-10-09
Assignee
INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
BUILDING 1, 6055 JINHAI ROAD, FENGXIAN DISTRICT, SHANGHAI, 201203, CHINA
Covered Properties (3)
Humanized Anti-CD19 Antibody and Use Thereof with Chimeric Antigen Receptor
Application: 15/876,538 →
Publication: US 2018/0153977
Humanized Anti-CD19 Antibody and Use Thereof with Chimeric Antigen Receptor
Application: 16/600,064 →
Publication: US 2020/0030424
HUMANIZED ANTl-CD19 ANTIBODY AND USE THEREOF WITH CHIMERIC ANTIGEN RECEPTOR
Application: 17/725,623 →
Publication: US 2022/0249638
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 22, 2018
From: WU, ZHAO; LIU, ZHIGANG; XIAO, LEI; PU, CHENGFEI
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 044688/0078 →
Assignment of Assignor's Interest Oct 31, 2019
From: WU, ZHAO; LIU, ZHIGANG; XIAO, LEI; PU, CHENGFEI
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 050881/0877 →
Assignment of Assignor's Interest Feb 8, 2021
From: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
To: INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS, LTD.
Reel/Frame 055181/0119 →
Assignment of Assignor's Interest Mar 28, 2025
From: WU, ZHAO; LIU, ZHIGANG; XIAO, LEI; PU, CHENGFEI
To: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
Reel/Frame 070667/0011 →
Assignment of Assignor's Interest Mar 28, 2025
From: INNOVATIVE CELLULAR THERAPEUTICS CO., LTD.
To: INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS, LTD.
Reel/Frame 070667/0524 →